Skip to main content

5 December 2022

Last updated: Sunday 4 December 2022

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

MorphoSys and Heptares explore new targets

Friday 8 March 2013

Interviewee/Contributor

Malcolm Weir

Organisation

Heptares Therapeutics Ltd

Organisations

Yorkville Advisors
Oslo Cancer Cluster, Radforsk
Avacta Life Sciences
Vertex Pharmaceuticals Inc
Innovation and International Relationship
Truffle Capital
Auspherix Ltd
Consultant
Evox Therapeutics Ltd
Leyden Laboratories BV

Interviewees and Contributers

Todd Sherer
Richard Holland
Jane Robertson
Jürg Eckhardt
Steff Taelman
Dawn Firmin
Marjanne Prins
Bruce Booth
Mark Vaeck
John Purves

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Stephen Burbidge to head research at Rewind Therapeutics

Sunday 4 December 2022

Richard Francis appointed CEO of Teva Pharmaceutical

Sunday 4 December 2022

Frank Mathias appointed CEO of Oxford Biomedica

Sunday 27 November 2022

Grünenthal appoints chief commercial officer

Sunday 27 November 2022

Richard Bungay joins Imophoron as CEO

Saturday 19 November 2022

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2022 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form